Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis: the ‘TRUNCATE-TB’ trial

Grantholders

  • Dr Patrick Phillips

    MRC Clinical Trials Unit